Wedbush Securities’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-78,000
| Closed | -$13K | – | 967 |
|
|
2018
Q2 | $13K | Buy |
78,000
+35,000
| +81% | +$5.83K | ﹤0.01% | 873 |
|
|
2018
Q1 | $39K | Buy |
43,000
+35,400
| +466% | +$32.1K | 0.01% | 795 |
|
|
2017
Q4 | $23K | Buy |
7,600
+2,000
| +36% | +$6.05K | ﹤0.01% | 841 |
|
|
2017
Q3 | $20K | Buy |
5,600
+1,125
| +25% | +$4.02K | ﹤0.01% | 825 |
|
|
2017
Q2 | $32K | Buy |
4,475
+1,300
| +41% | +$9.3K | ﹤0.01% | 817 |
|
|
2017
Q1 | $29K | Buy |
+3,175
| New | +$29K | ﹤0.01% | 821 |
|